Skip to main content
Midaxo logo

Midaxo

Security and trust center evidence

Midaxo is the leader in software solutions for corporate

midaxo.comNo-code and automationLast verified 2 Nov 2026

Summary

Midaxo has 1 registry-verified row, and 1 expired in the CertReports index, last verified 2 Nov 2026. The strongest row is CSA STAR: STAR Level 1 self-assessment (CAIQ). This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 2 Nov 2026, CertReports holds 1 registry-verified row and 1 expired row for Midaxo, drawn from the CSA STAR registry and the Data Privacy Framework list. Midaxo is listed in the CSA STAR registry for CSA STAR (STAR Level 1 self-assessment (CAIQ)), dated 11 Mar 2018. Midaxo previously appeared with EU-US Data Privacy Framework evidence, but the listing is no longer active and CertReports found no renewal as of 2 Nov 2026. No public evidence was found for SOC 2, ISO/IEC 27001, HIPAA and GDPR as of 2 Nov 2026; that is a gap in the public record, not a finding of non-coverage, and the vendor can supply it under NDA.

  • CSA STAR: STAR Level 1 self-assessment (CAIQ), verified as of 26 Oct 2026
  • EU-US Data Privacy Framework: Inactive, expired as of 2 Nov 2026

Facts only, each dated; nothing here is inferred, scored or advised.

Among no-code and automation vendors

1verified rows

Category median 1, across 113 indexed no-code and automation vendors. Midaxo has more verified rows than 49 percent of them.

corporate transactionsdeal managementdocument managementworkflow automation

Compliance grid

Subprocessors

No subprocessor list captured yet.

Change history

  1. 18 Sep 2026First indexed by CertReports2 evidence rows across 2 frameworks entered the index.

Similar vendors with evidence

Related by product tags and the No-code and automation category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.

Evidence against regulations

All regulations for Midaxo

How much of each regulation’s vendor requirements Midaxo’s public evidence reaches.

All articles